{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-024454","form_type":"8-K","ticker":"WGRX","cik":"0002030763","company_name":"Wellgistics Health, Inc.","filed_at":"2026-05-19T21:11:19+00:00","discovered_at":"2026-05-19T21:12:00.315957+00:00","generated_at":"2026-05-19T21:14:09.050153+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Wellgistics Q1 revenue $0.93M, net loss $7.7M; terminates Neuritek/WellCare LOIs; guides Q2 ~$1.78M","bullets":["Revenue $0.93M in Q1 2026 vs $0.49M Q4 2025; expects Q2 rev $1.78M (with $0.86M recognized through May 18).","Net operating loss $7.74M vs $32.43M prior year; EPS -$0.07 vs -$0.62 on 104.6M shares.","Wellgistics Pharmacy monthly rev grew from ~$0.1M (Nov 2025) to ~$0.6M (Apr 2026).","Terminated non-binding LOIs with Neuritek and WellCare; advanced discussions with Datavault AI for HaaS expansion.","Partnership with Tollo Health and NFL Alumni Health; Health Lives Here app launch targeted Aug 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-024454","json":"https://secwatch.observer/filing/0001493152-26-024454.json","markdown":"https://secwatch.observer/filing/0001493152-26-024454.md","text":"https://secwatch.observer/filing/0001493152-26-024454.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226024454/0001493152-26-024454-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226024454/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T21:14:09.050153+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0666fe2d18cce20d2699d318516aee9c7f4ddc56","claim":"Wellgistics Health, Inc. reported first quarter ended March 31, 2026 results: revenue $0.929 million, net income net operating loss of $7.742 million, EPS $0.07. Guidance initiated.","evidence_excerpt":"revenue opportunities,”noted Mr. Patel. First Quarter 2026 Corporate Highlights ● Sequential quarter over quarter revenue growth: ○ Q4-2025: $0.486 million ○ Q1-2026: $0.929 million ○ Q2-2026: The Company expects revenue of $1.775 million (projected, $0.86M already recognized through May 18, 2026) ● Added quantum key encryption functionality to the","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2030763/000149315226024454/0001493152-26-024454-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2026"},{"label":"Revenue","value":"$0.929 million"},{"label":"Net income","value":"net operating loss of $7.742 million"},{"label":"EPS","value":"$0.07"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}